Thomas B Ladd Selected Research

Tauopathies

1/2018

Designing antibodies against LRRK2-targeted tau epitopes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas B Ladd Research Topics

Disease

15	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 06/2006
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 07/2015
2	Amyloid Plaque 11/2012 - 05/2012
1	Tauopathies 01/2018
1	Neuroinflammatory Diseases 07/2015
1	Gliosis 07/2015
1	Parkinson Disease (Parkinson's Disease) 07/2015
1	Malaria 08/2006

Drug/Important Bio-Agent (IBA)

8	Amyloid (Amyloid Fibrils)IBA 01/2019 - 06/2008
6	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2019 - 06/2008
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2006
4	Peptides (Polypeptides)IBA 01/2018 - 06/2008
4	O-(glucuronic acid 2- sulfate)- (1- - 4)- O- (2,5)- anhydromannitol 6-sulfateIBA 04/2014 - 06/2008
2	Protein Isoforms (Isoforms)IBA 04/2014 - 06/2008
2	Amyloid beta-PeptidesIBA 06/2008 - 06/2008
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	EpitopesIBA 01/2018
1	SynucleinsIBA 07/2015
1	CationsIBA 07/2015
1	PresenilinsIBA 04/2014
1	tasiamide BIBA 12/2012
1	Presenilin-1IBA 06/2008
1	Pharmaceutical PreparationsIBA 06/2008
1	Gamma Secretase Inhibitors and ModulatorsIBA 06/2008
1	human signal peptide peptidase like 3IBA 08/2006
1	signal peptide peptidaseIBA 08/2006
1	Apolipoproteins E (ApoE)IBA 06/2006

Therapy/Procedure

4	Therapeutics 01/2018 - 06/2008